This inventor holds 2 USPTO granted patents. Top assignee: Other. Active years: 2005-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 834,601 Years Active: 2005-2006
Title: Pao-Hsien Chu: Innovator in Medical Treatments
Introduction
Pao-Hsien Chu is a notable inventor based in San Diego, CA. He has made significant contributions to the field of medical treatments, particularly in the areas of hepsin antagonists and macular degeneration therapies. With a total of 2 patents, his work has the potential to impact patient care positively.
Latest Patents
Chu's latest patents include a method for treating or preventing infarction in patients through the administration of a hepsin antagonist. This method aims to suppress or inactivate hepsin's expression over a sustained period. Additionally, he has developed methods for treating macular degeneration with topiramate. This approach involves administering topiramate in a dosage that is pharmaceutically effective to suppress degeneration or induce the growth of new optic nerve fibers over a sustained period.
Career Highlights
Throughout his career, Pao-Hsien Chu has focused on innovative solutions to complex medical issues. His research and inventions have garnered attention for their potential to improve treatment outcomes for patients suffering from serious conditions.
Collaborations
Chu has collaborated with esteemed colleagues, including Hosheng Tu and I-Shing Yu, to advance his research and develop effective treatment methods.
Conclusion
Pao-Hsien Chu's contributions to medical innovation highlight his dedication to improving patient care through his inventions. His work in developing treatments for infarction and macular degeneration showcases the importance of innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile